Prof David Gottlieb

Related Grants and Projects

• Participant in A Phase I Study of Autologous CD19 Specific Chimeric Antigen Receptor T-cells for Therapy of Relapsed and Refractory B-cell Leukaemia and Lymphoma (The Auto-CAR19 Trial). (funded by National Health and Medical Research Council)
• Participant in A Phase I Study of PiggyBac CD19 Specific Chimeric Antigen Receptor T-cells for Therapy of Persistent and Relapsed B-cell Leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study). (funded by National Health and Medical Research Council)
• Participant in Centre for Blood Transplant and Cell Therapy (funded by National Health and Medical Research Council)
• Participant in Development of a New Specific Immunosuppressive Monoclonal Antibody to Advance Transplantation (funded by National Health and Medical Research Council)